Health ❯Healthcare ❯Patient Care ❯Chronic Illness

Dementia

NHS Rejects Alzheimer’s Drug Donanemab Despite Promising Results

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs